1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67F7EB136B757CA9B00258C3100291FB1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/case-study-inside-the-first-fully-digital-pharma-launch-how-biohaven-launched-nurtec-successfully-during-the-pandemic?opendocument
18
19opendocument
2018.97.14.85
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25Main






Case Study: Inside the First Fully Digital Pharma Launch – How Biohaven Launched Nurtec Successfully During the Pandemic

CHAPEL HILL, N.C., Feb. 14, 2025/ -- Launching a new drug is always a challenge, but doing so amid a global pandemic without traditional sales reps and in-person physician detailing required a groundbreaking approach. Biohaven rose to the occasion, delivering the first fully digital pharma launch with Nurtec, a one-dose migraine treatment that disrupted the competitive migraine market and set a new industry standard. By leveraging an entirely digital strategy powered by direct-to-consumer (DTC) campaigns, social media engagement, and influencer-driven storytelling, Nurtec achieved rapid market penetration and widespread patient adoption. This case study explores the bold choices that fueled its success and reshaped pharma marketing.

What Pharma Leaders Can Learn from Nurtec's Digital-First Success:

  • Revolutionary Market Entry: A fully digital go-to-market strategy that bypassed traditional salesforce models.
  • Consumer-Centric Engagement: Social media, targeted advertising, and direct patient outreach fueled unprecedented awareness.
  • Rapid Adoption & Growth: A disruptive approach that propelled Nurtec to the forefront of the migraine treatment space.
The 67-page case study, “Pure Play Digital Launch: Launching a New Blockbuster Migraine Drug During a Global Pandemic,” provides a deep dive into the strategic decisions, digital innovations, and commercial execution that made Nurtec's launch a resounding success.

Key topics addressed in this case study:

  • Nurtec’s Journey: Transforming a new migraine treatment into a market leader through a digital-first strategy.
  • Market Entry: Navigating the competitive migraine landscape with innovative digital approaches.
  • Digital Innovation: The bold digital strategy behind Nurtec’s successful launch during the pandemic.
  • Sales Growth: A rapid uptake that shaped Nurtec’s success trajectory.
  • Strategic Partnerships: Leveraging digital platforms to extend reach and share funding.
  • Consumer Campaigns: Empowering disease education and showcasing Nurtec’s impact through digital channels.
  • Patient Services: Enhancing access, reimbursement, and patient support programs.

To learn more about this case study, download a complimentary report excerpt at https://www.best-in-class.com/rw441.htm


Pressed for time? Watch the short video summary below to uncover the key highlights from the case study:

 


 

 

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

For Media Inquiries:

Email: psingh@bestpracticesllc.com

Website: https://www.best-in-class.com